You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

5-alpha Reductase

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Benign Prostatic Hyperplasia, Prostate Hyperplasia, Prostate Disease Trial in Boston (Finasteride)

Recruiting
  • Benign Prostatic Hyperplasia
  • +7 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 26, 2022

Benign Prostatic Hyperplasia (BPH) Trial in France (REZUM, alpha blocker and 5-alpha reductase inhibitor)

Recruiting
  • Benign Prostatic Hyperplasia (BPH)
  • REZŪM
  • alpha blocker and 5-alpha reductase inhibitor
  • Aix-en-Provence, France
  • +9 more
Jul 26, 2022

C677T Methylenetetrahydrofolate Reductase Mutation

Completed
  • Mutation
  • infertily evaluation
  • (no location specified)
May 16, 2023

Benign Prostatic Hyperplasia Trial in Seoul (combination therapy, alpha blocker monotherapy, 5 alpha reductase inhibitor

Completed
  • Benign Prostatic Hyperplasia
  • combination therapy
  • +2 more
  • Seoul, Korea, Republic of
    Samsung Medical Center
Nov 28, 2019

Disorders of Sex Development (DSD) 46.XY in Three Siblings

Completed
  • Genotype
  • Karyotype
  • Bandung, Indonesia
    Department of Obstetrics and Gynecology, Universitas Padjadjaran
Jul 3, 2022

Benign Prostatic Hyperplasia Trial (Phosphodiesterase 5 Inhibitors, Alpha Blockers, Combined Alpha Blockers and

Not yet recruiting
  • Benign Prostatic Hyperplasia
  • Phosphodiesterase 5 Inhibitors
  • +2 more
  • (no location specified)
Feb 10, 2022

Baby Detect : Genomic Newborn Screening

Recruiting
  • Congenital Adrenal Hyperplasia
  • +126 more
    • Liege, Wallonia, Belgium
      CRMN, Hôpital La Citadelle
    Jan 24, 2023

    Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)

    Not yet recruiting
    • Depressive Disorder, Major
    • +2 more
    • New Haven, Connecticut
      Yale University
    Jun 26, 2023

    Prostatic Hyperplasia, Prostate Hyperplasia, Prostatic Hypertrophy Trial in Seoul (alpha-blocker or 5-ARI withdrawal,

    Recruiting
    • Prostatic Hyperplasia
    • +2 more
    • alpha-blocker or 5-ARI withdrawal
    • Maintenance of alpha-blocker and 5-ARI
    • Seoul, Korea, Republic of
      Gangnam Severance Hospital, Yonsei University College of Medicin
    Aug 21, 2021

    Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)

    Recruiting
    • Depressive Disorder, Major
    • +2 more
    • New Haven, Connecticut
      Yale University
    Aug 8, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast

    Not yet recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +2 more
    • Biopsy
    • +7 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Feb 23, 2023

    HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

    Recruiting
    • HLA-A2 Positive Cells Present
    • Refractory Melanoma
    • Alpha-type-1 Polarized Dendritic Cells
    • +5 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Dec 12, 2022

    Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PegIFN-alpha-2a, Tenofovir disoproxil)

    Terminated
    • Hepatitis B, Chronic
    • Hillsborough, New Jersey
    • +11 more
    Dec 28, 2022

    Atypical Endometrial Hyperplasia, Endometrial Carcinoma Trial in Duarte (Megestrol Acetate, Pterostilbene)

    Recruiting
    • Atypical Endometrial Hyperplasia
    • Endometrial Carcinoma
    • Megestrol Acetate
    • Pterostilbene
    • Duarte, California
      City of Hope Medical Center
    Oct 12, 2022

    Prostatic Hyperplasia, Prostate Cancer Trial in Turku (Prostate hyperplasia medication, LhRH-antagonist)

    Recruiting
    • Prostatic Hyperplasia
    • Prostate Cancer
    • Turku, Finland
    • +1 more
    Aug 17, 2023

    Mucositis (MeSH Unique ID: D052016), Stomatitis (MeSH Unique ID: D013280) Trial (1. alpha acid lipoic - tables, 2. ozonated oil

    Not yet recruiting
    • Mucositis (MeSH Unique ID: D052016)
    • Stomatitis (MeSH Unique ID: D013280)
    • 1. alpha acid lipoic - tables
    • +3 more
    • (no location specified)
    Jan 26, 2022

    Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma

    Recruiting
    • Stage III Hepatocellular Carcinoma AJCC v8
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 18, 2021

    Pulmonary Emphysema in Alpha-1 PI Deficiency Trial in Worldwide (Alpha-1 MP, 0.9% Sodium Chloride for Injection, USP)

    Recruiting
    • Pulmonary Emphysema in Alpha-1 PI Deficiency
    • Alpha-1 MP
    • 0.9% Sodium Chloride for Injection, USP
    • Phoenix, Arizona
    • +50 more
    Dec 7, 2022

    Myocardial Infarction, Statin Adverse Reaction, HMG-CoA Reductase Inhibitor Toxicity Trial in Korea, Republic of (Rosuzet 10/5

    Recruiting
    • Myocardial Infarction
    • +2 more
    • Ezetimibe 10mg + Rosuvastatin 5mg
    • Rosuvastatin 20mg
    • Bucheon, Gyeonggido, Korea, Republic of
    • +6 more
    Sep 2, 2022

    Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Edmonton ([131]I-IAZA)

    Withdrawn
    • Locally Advanced Solid Tumors
    • Metastatic Solid Tumors
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Jul 7, 2022

    Adolescent Migraine Trial in Bhubaneswar (Flunarizine 5mg, Alpha lipoic acid 300mg)

    Recruiting
    • Adolescent Migraine
    • Flunarizine 5mg
    • Alpha lipoic acid 300mg
    • Bhubaneswar, Odisha, India
      AIIMS
    Oct 26, 2021

    Lung Cancer Trial (TILT-123, Pembrolizumab)

    Not yet recruiting
    • Lung Cancer
    • TILT-123
    • Pembrolizumab
    • (no location specified)
    Nov 5, 2023

    Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency Trial in Worldwide (Alpha-1 MP)

    Enrolling by invitation
    • Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency
    • Alpha-1 MP
    • Phoenix, Arizona
    • +24 more
    Dec 7, 2022

    HNSCC Trial in Worldwide (Eftilagimod alpha, Pembrolizumab)

    Recruiting
    • HNSCC
    • Birmingham, Alabama
    • +28 more
    Nov 29, 2022

    Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Thymalfasin, Radiotherapy, PD-1/PD-L1 inhibitor)

    Recruiting
    • Advanced Solid Tumor
    • Refractory Tumor
    • Suzhou, China
      The Second Affiliated Hospital of SchoowUniversity
    Mar 29, 2023